Home › Sezary Syndrome › New Jersey
Sezary Syndrome clinical trials in New Jersey
3 studies for Sezary Syndrome are looking for participants at sites in New Jersey.
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- Hackensack University Medical Center - John Theurer Cancer C - Lymphoma Division, Hackensack
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07192471A Registry for People With T-cell Lymphoma
- Memorial Sloan Kettering at Basking Ridge (All protocol activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All protocol activities), Middletown
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 3, 2026 · NCT03587844From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.